Janssen Biopharma, Inc.
Records under this name other than the patents Janssen Biopharma, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 14 patents it holds.
Back to Janssen Biopharma, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,243,022 | Substituted Nucleosides, Nucleotides and Analogs Thereof Formerly held In force · High confidence | In force | High confidence | |
| US 9,249,174 | Substituted Nucleosides, Nucleotides and Analogs Thereof Formerly held In force · High confidence | In force | High confidence | |
| US 11,485,753 | Substituted Nucleosides, Nucleotides and Analogs Thereof Formerly held In force · High confidence | In force | High confidence | |
| US 12,173,025 | Substituted Nucleosides, Nucleotides and Analogs Thereof Formerly held In force · High confidence | In force | High confidence | |
| US 9,328,119 | Aza-Pyridone Compounds and Uses Thereof Formerly held In force · High confidence | In force | High confidence | |
| US 10,208,045 | Aza-Pyridone Compounds and Uses Thereof Formerly held In force · High confidence | In force | High confidence | |
| US 10,364,226 | Pyridazinone Compounds and Uses Thereof Formerly held In force · High confidence | In force | High confidence | |
| US 9,603,863 | Substituted Nucleosides, Nucleotides and Analogs Thereof Formerly held In force · High confidence | In force | High confidence | |
| US 9,603,864 | Substituted Nucleosides, Nucleotides and Analogs Thereof Formerly held In force · High confidence | In force | High confidence | |
| US 10,780,105 | Substituted Nucleosides, Nucleotides and Analogs Thereof Formerly held In force · High confidence | In force | High confidence |